These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8413038)

  • 1. The half-life of high dose rate Ir-192 sources.
    Podgorsak MB; DeWerd LA; Paliwal BR
    Med Phys; 1993; 20(4):1257-9. PubMed ID: 8413038
    [No Abstract]   [Full Text] [Related]  

  • 2. Monte Carlo calculation of dose rate distributions around 192Ir wires.
    Ballester F; Hernández C; Pérez-Calatayud J; Lliso F
    Med Phys; 1997 Aug; 24(8):1221-8. PubMed ID: 9284243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Size and positioning reproducibility of an 192Ir brachytherapy stepping source.
    Berndt A; Rickey DW; Rathee S; Bews J
    Med Phys; 2000 Jan; 27(1):129-31. PubMed ID: 10659747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetry of 192Ir wires for LDR interstitial brachytherapy following the AAPM TG-43 dosimetric formalism.
    Karaiskos P; Papagiannis P; Angelopoulos A; Sakelliou L; Baltas D; Sandilos P; Vlachos L
    Med Phys; 2001 Feb; 28(2):156-66. PubMed ID: 11243338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anisotropy functions for 103Pd, 125I, and 192Ir interstitial brachytherapy sources.
    Nath R; Meigooni AS; Muench P; Melillo A
    Med Phys; 1993; 20(5):1465-73. PubMed ID: 8289730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transit dose of an Ir-192 high dose rate brachytherapy stepping source.
    Wong TP; Fernando W; Johnston PN; Bubb IF
    Phys Med Biol; 2001 Feb; 46(2):323-31. PubMed ID: 11229717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current possibilities of utilizing covert sources of radiation in brachytherapy for neoplasia].
    Kanaev SV; Turkevich VG
    Vopr Onkol; 2007; 53(6):690-5. PubMed ID: 18416139
    [No Abstract]   [Full Text] [Related]  

  • 8. A method to avoid misadministrations in high dose rate brachytherapy.
    Alecu R; Feldmeier JJ; Court WS; Alecu M; Orton CG
    Med Phys; 1997 Feb; 24(2):259-61. PubMed ID: 9048366
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of a fiber-coupled Al2O3:C luminescence dosimetry system for online in vivo dose verification during 192Ir brachytherapy.
    Andersen CE; Nielsen SK; Greilich S; Helt-Hansen J; Lindegaard JC; Tanderup K
    Med Phys; 2009 Mar; 36(3):708-18. PubMed ID: 19378731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantation guidelines for 169 Yb seed interstitial treatments.
    Piermattei A; Azario L; Montemaggi P
    Phys Med Biol; 1995 Aug; 40(8):1331-8. PubMed ID: 7480116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources.
    Krishnamurthy D; Weinberg V; Cunha JA; Hsu IC; Pouliot J
    Brachytherapy; 2011; 10(6):461-5. PubMed ID: 21397569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nondivergent specification of the mean treatment dose in interstitial brachytherapy.
    Yu Y
    Med Phys; 1996 Jun; 23(6):905-9. PubMed ID: 8798176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta versus gamma dosimetry close to Ir-192 brachytherapy sources.
    Baltas D; Karaiskos P; Papagiannis P; Sakelliou L; Loeffler E; Zamboglou N
    Med Phys; 2001 Sep; 28(9):1875-82. PubMed ID: 11585218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dosimetric comparison of 169Yb versus 192Ir for HDR prostate brachytherapy.
    Lymperopoulou G; Papagiannis P; Sakelliou L; Milickovic N; Giannouli S; Baltas D
    Med Phys; 2005 Dec; 32(12):3832-42. PubMed ID: 16475783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In regard to Anagnostopoulos et al.: In vivo thermoluminescence dosimetry dose verification of transperinal (192)Ir high dose rate brachytherapy using CT-based planning for the treatment of prostate cancer (Int J Radiat Oncol Biol Phys 2003;57:1183-1191).
    Duggan L; Bucci J; Kron T
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):911; author reply 911-2. PubMed ID: 15183495
    [No Abstract]   [Full Text] [Related]  

  • 16. A Monte Carlo investigation of the dosimetric characteristics of the VariSource 192Ir high dose rate brachytherapy source.
    Karaiskos P; Angelopoulos A; Baras P; Sakelliou L; Sandilos P; Dardoufas K; Vlachos L
    Med Phys; 1999 Aug; 26(8):1498-502. PubMed ID: 10501049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement and calculation of the dose at large distances from brachytherapy sources: Cs-137, Ir-192, and Co-60.
    Venselaar JL; van der Giessen PH; Dries WJ
    Med Phys; 1996 Apr; 23(4):537-43. PubMed ID: 9157267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dosimetric comparison of 169Yb and 192Ir for HDR brachytherapy of the breast, accounting for the effect of finite patient dimensions and tissue inhomogeneities.
    Lymperopoulou G; Papagiannis P; Angelopoulos A; Karaiskos P; Georgiou E; Baltas D
    Med Phys; 2006 Dec; 33(12):4583-9. PubMed ID: 17278810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement and calculation of heterogeneity correction factors for an Ir-192 high dose-rate brachytherapy source behind tungsten alloy and steel shields.
    Kirov AS; Williamson JF; Meigooni AS; Zhu Y
    Med Phys; 1996 Jun; 23(6):911-9. PubMed ID: 8798161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interstitial radiotherapy using iridium-192].
    Veen RE
    Ned Tijdschr Geneeskd; 1987 Nov; 131(46):2063-8. PubMed ID: 3683635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.